Evidence map›Paper›PMID 42557845›Full record

ArticleJournal of biochemical and molecular toxicology2026

Barbaloin Attenuates Cisplatin-Induced Hippocampal Neurotoxicity by Suppressing Oxidative Stress, Neuroinflammation, and Apoptosis: In Vivo and In Silico Evidence.

Rahamat Unissa Syed, Rihab Akasha, Nancy Mohammad Elafandy, Sally Hassan Abobaker, Afrah Nashmi Al-Shammari, Lama Abdullah Altwalah, Rawabi Mohammed Menwer Aldafeeri, Amira Ibrahim Mohammed Ahmed Alfaki, Mohd Sajjad Ahmad Khan, Ashgan A Ahmed

Abstract read
In one paragraph

Article in Journal of biochemical and molecular toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rahamat Unissa SyedDepartment of Pharmaceutics, College of Pharmacy, University of Hai'l, Hai'l, Saudi Arabia.ORCID https://orcid.org/0009-0008-5401-2564
Rihab AkashaDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Hai'l, Hai'l, Saudi Arabia.
Nancy Mohammad ElafandyDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Hai'l, Hai'l, Saudi Arabia.
Sally Hassan AbobakerDepartment of Basic Dental and Medical Sciences, College of Dentistry, University of Hai'l, Hai'l, Saudi Arabia.
Afrah Nashmi Al-ShammariCollege of Pharmacy, University of Hai'l, Hai'l, Saudi Arabia.
Lama Abdullah AltwalahCollege of Pharmacy, University of Hai'l, Hai'l, Saudi Arabia.
Rawabi Mohammed Menwer AldafeeriCollege of Pharmacy, University of Hai'l, Hai'l, Saudi Arabia.
Amira Ibrahim Mohammed Ahmed AlfakiKing Salman Specialist Hospital, Ha'il, Saudi Arabia.
Mohd Sajjad Ahmad KhanDepartment of Basic Sciences, Deanship of Preparatory Year and Supporting Studies, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Ashgan A AhmedFaculty of Medical and Health Sciences, Liwa University, Al Ain, UAE.

Funding

Scientific Research Deanship at the University of Ha'il - Saudi Arabia RG-25069
6 · The paper itself

Abstract

The neurotoxicity of cisplatin (CIS) in the hippocampal leads to cognitive effects caused by oxidative stress, neuroinflammation, apoptosis, and dysfunction of neurotransmitters. The major bioactive phytonutrient in Aloe vera is barbaloin (BLN), which has been shown to have antioxidant and anti-inflammatory effects, but its neuroprotective ability against CIS-induced neurotoxicity has not been investigated. To assess the neuroprotective action of BLN in CIS-induced hippocampal neurotoxicity in rats and to understand the molecular interactions between BLN and major neuroinflammatory and apoptotic proteins. A total of 24 male Wistar rats were split into 4 groups (n = 6): control, CIS (5 mg/kg), CIS + BLN 25 mg/kg, and CIS + BLN 50 mg/kg over 21 days. Cognitive ability (Morris water maze), oxidative stress indicators (MDA, GSH, SOD, CAT), neuroinflammatory cytokines (TNF-α, IL-1β, IL-6, NF-κB, TGF-β1), caspase-3, neurotransmitters, and hippocampal histopathology were measured. Molecular docking and 100-ns molecular dynamics simulations (MDS) with MM-GBSA analysis were done with TNF-α, TGF-β1, NF-κBp65, and caspase-3. BLN significantly reduced cognitive impairment, oxidative stress, neuroinflammation, and apoptosis, and restored neurotransmitter homeostasis and hippocampal cytoarchitecture (all p < 0.0001). Molecular docking demonstrated positive binding energies (- 7.226 to -8.566 kcal/mol), and MDS revealed the presence of stable BLN-protein complexes (ΔG

Indexed as

ApoptosisCisplatinHippocampusNeuroinflammatory DiseasesNeuroprotective AgentsOxidative StressAnimalsMaleMolecular Docking SimulationRatsRats, WistarCisplatinNeuroprotective AgentsAloe verabarbaloincisplatinin silicoin vivophytonutrient

Identifiers

PMID42557845
PMCPMC13443480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.